Safety of Insulin Lispro and a Biosimilar Insulin Lispro When Administered Through an Insulin Pump

Abstract

Both SAR-Lis and Ly-Lis were well tolerated by patients using insulin pumps. The results do not suggest a clinically significant difference in the risk of ISO between SAR-Lis and Ly-Lis when used in CSII.